Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Privia Health (PRVA) EPS (Weighted Average and Diluted) (2020 - 2026)

Privia Health has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at $0.07 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 133.33% year-over-year to $0.07; the TTM value through Dec 2025 reached $0.17, up 54.55%, while the annual FY2025 figure was $0.18, 63.64% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.07 at Privia Health, up from $0.05 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.16 in Q4 2022 and troughed at -$1.68 in Q2 2021.
  • A 5-year average of -$0.07 and a median of $0.03 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 2900.0% in 2021 and later soared 400.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.09 in 2021, then surged by 277.78% to $0.16 in 2022, then plummeted by 81.25% to $0.03 in 2023, then changed by 0.0% to $0.03 in 2024, then soared by 133.33% to $0.07 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PRVA at $0.07 in Q4 2025, $0.05 in Q3 2025, and $0.02 in Q2 2025.